Clinical Trials Directory

Trials / Completed

CompletedNCT03250520

Application of Palliative Treatment in Children With Brain Stem Glioma and Recurrent High-grade Tumors in the Central Nervous System With the Nanomaterial NPt-Ca

Pilot Study of the Application of Palliative Treatment in Children With Brain Stem Glioma and Recurrent High-grade Tumors in the Central Nervous System With the Nanomaterial Platinum Acetylacetonate (1% wt) Supported by Sol-gel Technology Functionalized Titania (NPt-Ca)

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Hospital Infantil de Mexico Federico Gomez · Academic / Other
Sex
All
Age
5 Years – 14 Years
Healthy volunteers
Not accepted

Summary

This Protocol is a pilot, clinical interventional study to selected patients between five and fourteen years of both sexes, carriers of the diagnosis of glioma brain stem and high grade recurrent in the central nervous system tumors, in whom there has been no response to conventional-based surgery/radiation/chemotherapy treatment or whose location does not allow treatment with conventional measures, and that already have an indication for a neurosurgical palliative procedure. It will be a close pharmacovigilance on possible adverse effects related to the nanomaterial based on the profile of cisplatin (chemotherapeutic platinum derivative), since documented toxicity data are not counted for NPt-Ca. Quality of life will be documented with PedsQL Cancer Module© and tumor size by magnetic resonance brain images.

Conditions

Interventions

TypeNameDescription
DRUGPlatinum acetylacetonate (1% wt) supported by sol-gel technology functionalized titaniaSol-gel process Pt(acac)2- F-TiO2 nanostructured material with antitumoral activity used as an alternative in the treatment of cancer tumors. The biocatalysts were prepared by the sol-gel route using the complex Pt(acac)2.

Timeline

Start date
2017-09-01
Primary completion
2022-01-28
Completion
2022-06-28
First posted
2017-08-15
Last updated
2023-02-28

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT03250520. Inclusion in this directory is not an endorsement.